Cargando…
Discovery of Potential Therapeutic Drugs for COVID-19 Through Logistic Matrix Factorization With Kernel Diffusion
Coronavirus disease 2019 (COVID-19) is rapidly spreading. Researchers around the world are dedicated to finding the treatment clues for COVID-19. Drug repositioning, as a rapid and cost-effective way for finding therapeutic options from available FDA-approved drugs, has been applied to drug discover...
Autores principales: | Tian, Xiongfei, Shen, Ling, Gao, Pengfei, Huang, Li, Liu, Guangyi, Zhou, Liqian, Peng, Lihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919055/ https://www.ncbi.nlm.nih.gov/pubmed/35295301 http://dx.doi.org/10.3389/fmicb.2022.740382 |
Ejemplares similares
-
RNMFMDA: A Microbe-Disease Association Identification Method Based on Reliable Negative Sample Selection and Logistic Matrix Factorization With Neighborhood Regularization
por: Peng, Lihong, et al.
Publicado: (2020) -
Identifying Effective Antiviral Drugs Against SARS-CoV-2 by Drug Repositioning Through Virus-Drug Association Prediction
por: Peng, Lihong, et al.
Publicado: (2020) -
Drug repositioning for SARS-CoV-2 by Gaussian kernel similarity bilinear matrix factorization
por: Wang, Yibai, et al.
Publicado: (2022) -
An Inductive Logistic Matrix Factorization Model for Predicting Drug-Metabolite Association With Vicus Regularization
por: Ma, Yuanyuan, et al.
Publicado: (2021) -
A novel lncRNA–protein interaction prediction method based on deep forest with cascade forest structure
por: Tian, Xiongfei, et al.
Publicado: (2021)